CD4 and acute myeloid leukemia: CTLA-4 overexpression has been reported in CD4+CD25+ T cells co-cultured with IDO-expressing acute myeloid leukemia (AML) cells, and this effect is completely abrogated by the IDO-inhibitor 1-methyl tryptophan (1-MT) (193).